Trevi Therapeutics Inc.

NASDAQ: TRVI · Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Trevi Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-8.69 -4.57 -4.27 -0.53
PEG Ratio
-0.14 0.13 0.06 0.03
PS Ratio
n/a n/a n/a n/a
PB Ratio
4.18 1.61 1.16 1.05
P/FCF Ratio
-10.87 -4.17 -4.4 -0.62
P/OCF Ratio
-10.88 -4.18 -4.42 -0.62
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.01 0.02 0.09 0.86
Quick Ratio
10.41 15.03 9.15 2.98
Current Ratio
10.41 15.03 9.15 2.98
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-12.88K -86.76 -38.34 -27.02
Return on Equity
-0.48 -0.35 -0.27 -1.99
Return on Assets
-0.43 -0.33 -0.24 -0.88
Return on Invested Capital
-0.51 -0.4 -0.26 -1.02
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a